Nocturnal hypertension defined by fixed cut-off limits is a better predictor of left ventricular hypertrophy than

Insights

Nocturnal hypertension, defined by fixed blood pressure cut-offs, better predicts left ventricular hypertrophy than the non-dipping classification. This finding aids in identifying cardiovascular risks more reliably.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Diagnostic Predictors

Background:

  • Nocturnal hypertension classification lacks reproducibility, particularly the non-dipping (systolic blood pressure fall <10%) method.
  • Fixed cut-off limits for nocturnal blood pressure (mean >120/70 mm Hg) offer a potentially more stable classification.
  • Left ventricular hypertrophy (LVH) is a significant indicator of cardiovascular disease.

Purpose of the Study:

  • To evaluate if fixed cut-off limits for nocturnal hypertension are superior predictors of left ventricular hypertrophy compared to the non-dipping classification.
  • To compare the predictive value of two distinct definitions of nocturnal hypertension for LVH.

Main Methods:

  • Utilized 24-hour ambulatory blood pressure monitoring in 223 subjects.
  • Performed echocardiography to assess left ventricular hypertrophy.
  • Employed logistic regression analysis to determine the predictive significance of nocturnal hypertension definitions for LVH.

Main Results:

  • Nocturnal hypertension defined by fixed cut-off limits significantly predicted LVH (Odds Ratio=11.1, 95% Confidence Interval=3.0-40.1).
  • The non-dipping classification did not show a significant association with LVH (Odds Ratio=1.4, 95% Confidence Interval=0.4-5.5).
  • No interaction was observed between the two classification methods (p<0.3).

Conclusions:

  • Fixed cut-off values for defining nocturnal hypertension are more effective predictors of left ventricular hypertrophy than the non-dipping criterion.
  • This suggests a more reliable method for identifying individuals at risk for cardiac structural changes associated with hypertension.

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...